Author's response: Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation

Affiliations

¹ The Genomics Research Center, Academia Sinica, Taipei, Taiwan.
² The Genomics Research Center, Academia Sinica, Taipei, Taiwan Molecular and Genomic Epidemiology Center, China Medical University Hospital, Taichung, Taiwan Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.
³ The Genomics Research Center, Academia Sinica, Taipei, Taiwan Graduate Institute of Epidemiology and Preventative Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

Comment

Jessica Liu et al. Gut. 2015 Jan.

. 2015 Jan;64(1):186-7.

doi: 10.1136/gutjnl-2014-306718. Epub 2014 Feb 4.

¹ The Genomics Research Center, Academia Sinica, Taipei, Taiwan.
² The Genomics Research Center, Academia Sinica, Taipei, Taiwan Molecular and Genomic Epidemiology Center, China Medical University Hospital, Taichung, Taiwan Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.
³ The Genomics Research Center, Academia Sinica, Taipei, Taiwan Graduate Institute of Epidemiology and Preventative Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

No abstract available

Keywords: Hepatitis B; Hepatocellular Carcinoma.

Comment on

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma.
Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Batrla-Utermann R, Wang LY, You SL, Hsiao CK, Chen PJ, Chen CJ; R.E.V.E.A.L.-HBV Study Group. Liu J, et al. Gut. 2014 Oct;63(10):1648-57. doi: 10.1136/gutjnl-2013-305785. Epub 2013 Nov 13. Gut. 2014. PMID: 24225939
Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation.
Pariente A. Pariente A. Gut. 2015 Jan;64(1):186. doi: 10.1136/gutjnl-2013-306530. Epub 2014 Jan 2. Gut. 2015. PMID: 24385597 No abstract available.